Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Stopped The study was terminated before reaching its accrual goal due to slow accrual.
Conditions
- Adenocarcinoma of the Rectum
- Stage II Rectal Cancer
- Stage III Rectal Cancer
Interventions
- DRUG: oxaliplatin
- DRUG: fluorouracil
- DRUG: leucovorin calcium
- DRUG: bevacizumab
Sponsor
ECOG-ACRIN Cancer Research Group
Collaborators